In the present work, we aimed to test whether knockdown of either CREB or HIF-1 in UM mouse xenograft models will be as effective at attenuating UM tumor growth in vivo as is the knockdown of these genes at reducing UM cell survival in vitro and in HCC growth in vitro and in vivo. The gene discussed is CREB1; the disease is neoplasm.